Farther Finance Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in REGN

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$1,444,836

-$92,729 QoQ

Shares Held

1,870

-6.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $14,686,998 across 278 Biotechnology names. REGN ranks #2 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,752	$2,121,958
2	REGN	Regeneron Pharmaceuticals, Inc. This page	1,870	$1,444,836
3	MRNA	Moderna, Inc.	20,211	$1,026,718
4	SMMT	Summit Therapeutics Inc.	50,316	$953,991
5	HALO	Halozyme Therapeutics, Inc.	13,333	$861,711
6	ARWR	Arrowhead Pharmaceuticals, Inc.	11,971	$750,581
7	EXEL	Exelixis, Inc.	16,443	$705,240
8	BMRN	Biomarin Pharmaceutical Inc	7,857	$443,841

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,444,836	1,870	-6.1%	Shares	Sole	2026-04-07
2025-12-31	$1,537,565	1,992	+34.7%	Shares	Sole	2026-01-23
2025-09-30	$831,597	1,479	+134.4%	Shares	Sole	2025-10-14
2025-06-30	$331,275	631	+0.5%	Shares	Sole	2025-07-11
2025-03-31	$398,296	628	+9.6%	Shares	Sole	2025-04-14
2024-12-31	$408,165	573	-20.9%	Shares	Sole	2025-02-10
2024-09-30	$761,097	724	+7.9%	Shares	Sole	2024-10-29
2024-06-30	$705,241	671	+4.8%	Shares	Sole	2024-07-31
2024-03-31	$615,993	640	+0.6%	Shares	Sole	2024-05-14
2023-12-31	$558,592	636	+30.6%	Shares	Sole	2024-02-15
2023-09-30	$400,781	487	+64.0%	Shares	Sole	2023-11-14
2023-06-30	$213,406	297	+175.0%	Shares	Sole	2024-05-14
2023-03-31	$88,740	108	+1.9%	Shares	Sole	2024-05-14
2022-12-31	$76,477	106	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.